Skip to content
Research/Longevity Diagnostics/Extended Serum Biomarker and Hormonal Panel

Extended Serum Biomarker and Hormonal Panel

The Extended Serum Biomarker and Hormonal Panel is a comprehensive diagnostic tool that measures various biomarkers and hormones in the blood to assess overall health and identify potential longevity-related issues. By providing detailed insights into metabolic, hormonal, and inflammatory states, this panel aids in personalized health optimization and early detection of age-related conditions.

Intelligence Profile

Clinical Applications

The "Extended Serum Biomarker and Hormonal Panel" is investigated for applications in diagnosing and managing various health conditions by analyzing specific biomarkers and hormonal profiles.

  1. Alzheimer’s Disease: The use of a nutraceutical combination has been studied for its impact on oxidative stress biomarkers in both healthy individuals and patients with Alzheimer's disease. This suggests potential use in monitoring oxidative stress levels, which may play a role in Alzheimer’s pathophysiology (Nutrients, 2026).

  2. HIV-Associated Pulmonary Infections: Serum Amyloid A (SAA) has been evaluated for its diagnostic value in HIV-associated pulmonary infections. It correlates with inflammatory markers, indicating its utility in assessing inflammation levels and aiding in the diagnosis of related complications (BMC Infectious Diseases, 2025).

  3. Knee Osteoarthritis in Obesity: In obese adults with knee osteoarthritis, strawberries have been shown to decrease circulating levels of tumor necrosis factor and lipid peroxides. This reveals the potential of dietary components to influence biomarkers related to inflammation and oxidative stress, which are pertinent in osteoarthritis management (Food & Function, 2018).

  4. Chronic Corticosteroid Use in Children: There is evidence of specific serum pharmacodynamic biomarkers being utilized to monitor the impact of chronic corticosteroid treatment in children, possibly informing dosing and minimizing side effects (Scientific Reports, 2016).

  5. Liver Steatosis in PCOS: An upcoming trial (NCT07731373) aims to recruit participants to explore biomarker panels for identifying liver steatosis in adolescents with polycystic ovary syndrome (PCOS). This reflects an interest in using biomarkers to improve the understanding and management of metabolic complications associated with PCOS.

  6. Acute Kidney Injury and Cardio-Renal Syndrome: Neutrophil gelatinase-associated lipocalin (NGAL) serves as a biomarker for the early diagnosis of acute kidney injury and cardio-renal syndrome, showcasing a novel approach in detecting renal complications early (Seminars in Nephrology, 2012).

The applications of this panel span several conditions, primarily for diagnostic purposes and monitoring disease states or treatment effects. However, much of its potential is emerging or being actively researched, indicating that clinical utility may expand as further studies are conducted.

Disclaimer: This content is for informational purposes only. For medical advice, please consult a healthcare professional.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.